Found: 40
Select item for more details and to access through your institution.
Patients with naproxen‐induced liver injury display T‐cell memory responses toward an oxidative (S)‐O‐desmethyl naproxen metabolite but not the acyl glucuronide.
- Published in:
- Allergy, 2024, v. 79, n. 1, p. 200, doi. 10.1111/all.15830
- By:
- Publication type:
- Article
Drug‐specific T‐cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1825, doi. 10.1111/all.14652
- By:
- Publication type:
- Article
Characterization of amoxicillin and clavulanic acid specific T‐cell clones from patients with immediate drug hypersensitivity.
- Published in:
- Allergy, 2020, v. 75, n. 10, p. 2562, doi. 10.1111/all.14298
- By:
- Publication type:
- Article
The Generation, Detection, and Effects of Reactive Drug Metabolites.
- Published in:
- Medicinal Research Reviews, 2013, v. 33, n. 5, p. 985, doi. 10.1002/med.21273
- By:
- Publication type:
- Article
Drug hapten‐specific T‐cell activation: Current status and unanswered questions.
- Published in:
- Proteomics, 2021, v. 21, n. 17/18, p. 1, doi. 10.1002/pmic.202000267
- By:
- Publication type:
- Article
Glycolysis: An early marker for vancomycin‐specific T‐cell activation.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 1, p. 21, doi. 10.1111/cea.14423
- By:
- Publication type:
- Article
Pathology of drug hypersensitivity reactions and mechanisms of immune tolerance.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 12, p. 1379, doi. 10.1111/cea.14235
- By:
- Publication type:
- Article
Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 5, p. 600, doi. 10.1111/cea.14134
- By:
- Publication type:
- Article
Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.
- Published in:
- British Journal of Pharmacology, 2001, v. 133, n. 2, p. 295, doi. 10.1038/sj.bjp.0704074
- By:
- Publication type:
- Article
Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
- Published in:
- British Journal of Pharmacology, 2001, v. 132, n. 3, p. 623, doi. 10.1038/sj.bjp.0703845
- By:
- Publication type:
- Article
Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Metabolism of lamotrigine to a chemically reactive metabolite(s) in vivo: possible role in cutaneous reactions.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 48, n. 6, p. 876P
- By:
- Publication type:
- Article
Immunological Principles of Adverse Drug Reactions.
- Published in:
- Drug Safety, 2000, v. 23, n. 6, p. 483, doi. 10.2165/00002018-200023060-00002
- By:
- Publication type:
- Article
A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessment.
- Published in:
- Toxicological Sciences, 2024, v. 197, n. 1, p. 38, doi. 10.1093/toxsci/kfad101
- By:
- Publication type:
- Article
Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury.
- Published in:
- Toxicological Sciences, 2023, v. 192, n. 1, p. 106, doi. 10.1093/toxsci/kfad015
- By:
- Publication type:
- Article
Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01.
- Published in:
- Toxicological Sciences, 2021, v. 183, n. 1, p. 139, doi. 10.1093/toxsci/kfab084
- By:
- Publication type:
- Article
Shedding Light on Drug-Induced Liver Injury: Activation of T Cells From Drug Naive Human Donors With Tolvaptan and a Hydroxybutyric Acid Metabolite.
- Published in:
- Toxicological Sciences, 2021, v. 179, n. 1, p. 95, doi. 10.1093/toxsci/kfaa157
- By:
- Publication type:
- Article
HLA DRB1*15:01-DQB1*06:02-Restricted Human CD4+ T Cells Are Selectively Activated With Amoxicillin-Peptide Adducts.
- Published in:
- Toxicological Sciences, 2020, v. 178, n. 1, p. 115, doi. 10.1093/toxsci/kfaa128
- By:
- Publication type:
- Article
Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and Presentation.
- Published in:
- Toxicological Sciences, 2020, v. 177, n. 2, p. 454, doi. 10.1093/toxsci/kfaa124
- By:
- Publication type:
- Article
Development of an Improved T-cell Assay to Assess the Intrinsic Immunogenicity of Haptenic Compounds.
- Published in:
- Toxicological Sciences, 2020, v. 175, n. 2, p. 266, doi. 10.1093/toxsci/kfaa034
- By:
- Publication type:
- Article
Characterization of Healthy Donor-Derived T-Cell Responses Specific to Telaprevir Diastereomers.
- Published in:
- Toxicological Sciences, 2019, v. 168, n. 2, p. 597, doi. 10.1093/toxsci/kfz007
- By:
- Publication type:
- Article
Characterization of Drug-Specific Signaling Between Primary Human Hepatocytes and Immune Cells.
- Published in:
- Toxicological Sciences, 2017, v. 158, n. 1, p. 76, doi. 10.1093/toxsci/kfx069
- By:
- Publication type:
- Article
Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury.
- Published in:
- Toxicological Sciences, 2017, v. 155, n. 2, p. 420, doi. 10.1093/toxsci/kfw218
- By:
- Publication type:
- Article
Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity.
- Published in:
- Toxicological Sciences, 2016, v. 154, n. 2, p. 416, doi. 10.1093/toxsci/kfw177
- By:
- Publication type:
- Article
Effect of Repeated Daily Dosing with 2,4-Dinitrochlorobenzene on Glutathione Biosynthesis and Nrf2 Activation in Reconstructed Human Epidermis.
- Published in:
- Toxicological Sciences, 2016, v. 154, n. 1, p. 5, doi. 10.1093/toxsci/kfw140
- By:
- Publication type:
- Article
Activation of Flucloxacillin-Specific CD81 T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse Model.
- Published in:
- Toxicological Sciences, 2015, v. 146, n. 1, p. 146, doi. 10.1093/toxsci/kfv077
- By:
- Publication type:
- Article
The Development of In Vitro Culture Methods to Characterize Primary T-Cell Responses to Drugs.
- Published in:
- Toxicological Sciences, 2012, v. 127, n. 1, p. 150, doi. 10.1093/toxsci/kfs080
- By:
- Publication type:
- Article
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00895-z
- By:
- Publication type:
- Article
Characterization of p-Phenylenediamine–Albumin Binding Sites and T-Cell Responses to Hapten-Modified Protein.
- Published in:
- Journal of Investigative Dermatology, 2010, v. 130, n. 3, p. 732, doi. 10.1038/jid.2009.271
- By:
- Publication type:
- Article
Measurement of CD4+ and CD8+ T-Lymphocyte Cytokine Secretion and Gene Expression Changes in p-Phenylenediamine Allergic Patients and Tolerant Individuals.
- Published in:
- Journal of Investigative Dermatology, 2010, v. 130, n. 1, p. 161, doi. 10.1038/jid.2009.187
- By:
- Publication type:
- Article
Activation of T-Cells from Allergic Patients and Volunteers by p-Phenylenediamine and Bandrowski's Base.
- Published in:
- Journal of Investigative Dermatology, 2008, v. 128, n. 4, p. 897, doi. 10.1038/sj.jid.5701071
- By:
- Publication type:
- Article
Immune dysregulation increases the incidence of delayed‐type drug hypersensitivity reactions.
- Published in:
- Allergy, 2020, v. 75, n. 4, p. 781, doi. 10.1111/all.14127
- By:
- Publication type:
- Article
Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA‐B*57:01 binding and T‐cell activation.
- Published in:
- Allergy, 2020, v. 75, n. 3, p. 636, doi. 10.1111/all.14057
- By:
- Publication type:
- Article
Dapsone‐ and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B*13:01.
- Published in:
- Allergy, 2019, v. 74, n. 8, p. 1533, doi. 10.1111/all.13769
- By:
- Publication type:
- Article
Challenges and approaches for the development of safer immunomodulatory biologics.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 4, p. 306, doi. 10.1038/nrd3974
- By:
- Publication type:
- Article
Managing the challenge of chemically reactive metabolites in drug development.
- Published in:
- 2011
- By:
- Publication type:
- journal article
T‐cell‐mediated hypersensitivity to lumacaftor and ivacaftor in cystic fibrosis.
- Published in:
- Pediatric Allergy & Immunology, 2022, v. 33, n. 6, p. 1, doi. 10.1111/pai.13815
- By:
- Publication type:
- Article
HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 11, p. 1260, doi. 10.1093/ced/llad282
- By:
- Publication type:
- Article
Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.658593
- By:
- Publication type:
- Article
Trimethoprim-induced aseptic meningism.
- Published in:
- British Journal of Hospital Medicine (17508460), 2017, v. 78, n. 2, p. 108, doi. 10.12968/hmed.2017.78.2.108
- By:
- Publication type:
- Article